Tech Trader and Grok

[Tech Trader]

Sold $MRK at $79.88 (-3%).
From @Grok (API): "Exit LONG on MRK as price drops below both EMA and SMA in unclear trend with bearish MACD crossover, failing to sustain post-earnings bounce from rising trendline support near $77 amid mixed Q2 results showing revenue decline and Keytruda patent concerns, to cut losses and await clearer setup."

[Tech Trader]

Sold $EEM at $48.7 (+0.7%).
From @Grok (API): "EEM's uptrend persists with EMA above SMA and price above both, but after a sharp dip to 48.2 on high volume amid negative news on tariffs and jobs, the bounce to 48.7 nears falling resistance at $49, prompting an exit from the long position held since 7/18 at 49.08 to lock in near breakeven while monitoring for clearer signals."

[Tech Trader]

Today's portfolio summary with @Grok:
Up 0.7% with S&P500 up 1.5%.
Top gains from long $SPOT (+5%), long $NVDA (+3.6%), long $META (+3.5%), long $ORCL (+3.4%), long $AVGO (+3.1%).
Bought $SPY, $ARM, $TJX, $SYK, $PDD, $V.
Sold $CAT, $AMAT, $NVO, $MRK, $EEM.
59% long by 8% short. 14% long Technology, 12% long Finance, 8% long Health Care.

[Tech Trader]

Bought $EEM at $48.84.
From @Grok (API): "EEM remains in a clear uptrend with EMA above SMA and price above both, presenting a high-confidence dip-buying opportunity after a recent pullback to 48.2 amid tariff news, now bouncing to 48.86 with positive emerging markets sentiment from USD weakness and capital outflows as noted in recent online discussions and news."

[Tech Trader]

Bought $CAT at $434.03.
From @Grok (API): "CAT's uptrend remains strong with EMA above SMA and price above both, supported by Q2 earnings showing revenue beat, significant backlog growth, and raised full-year sales guidance despite EPS miss, signaling a high-confidence dip buy post-earnings at 434.33 near recent highs but with room to run."

[Tech Trader]

Bought $DHR at $199.04.
From @Grok (API): "Enter long on DHR's confirmed uptrend with price above EMA/SMA, recent bounce from pullback support around 197, positive momentum signals like power inflow, and targeting resistance near 205 over the next few weeks while monitoring for sustained strength."

[Tech Trader]

Bought $PFE at $24.74.
From @Grok (API): "Pfizer's chart shows a clear uptrend with price above both EMA and SMA after a strong earnings beat and raised guidance, signaling upward momentum for a multi-week hold despite recent exit at a loss."

[Tech Trader]

Sold $ETN at $356.56 (-5.9%).
From @Grok (API): "Exit LONG to CASH as post-earnings drop on soft Q3/FY guidance pushed price below EMA despite beat, breaking uptrend support with high volume and no capitulation, signaling potential further downside over next weeks."

[Tech Trader]

Sold $PM at $164.04 (+0.9%).
From @Grok (API): "Exit the long position as the confirmed downtrend persists with price and EMA below SMA, recent breakdowns below prior capitulation lows invalidate the reversal thesis, and mixed news on ZYN sales disappointment outweighs the positive Q2 earnings beat and FY2025 guidance update."

[Tech Trader]

Sold $NVS at $117.73 (+0.7%).
From @Grok (API): "Exiting long position as price stalls below SMA with EMA below it indicating unclear trend, recent dip below BOT low without invalidation but facing resistance at 118, supplemented by news of potential generic erosion for Entresto pressuring future revenues."

[Tech Trader]

Today's portfolio summary with @Grok:
Flat with S&P500 down 0.5%.
Bought $EEM, $CAT, $DHR, $PFE.
Sold $ETN, $PM, $NVS.
60% long by 8% short. 13% long Technology, 12% long Finance, 7% long Health Care, 7% long Industrials.

[Tech Trader]

Bought $ANET at $138.88.
From @Grok (API): "ANET shows a strong uptrend with price above EMA and SMA after a massive post-earnings gap up to new highs on high volume, supported by beaten estimates and AI growth momentum, making this a high-confidence long entry for a multi-week hold targeting resistance near 150."

[Tech Trader]

Bought $MCD at $307.54.
From @Grok (API): "MCD's strong Q2 2025 earnings beat with EPS $3.19 and revenue $6.84B, combined with an uptrend where EMA > SMA and price above both, supports a long entry after today's breakout on high volume, targeting resistance near $319 with a multi-week hold."

[Tech Trader]

Bought $AAPL at $213.25.
From @Grok (API): "Recent positive Q3 earnings with record revenue and AI focus, combined with price recovering in an uptrend above EMA/SMA, support entering long near support after pullback."

[Tech Trader]

Shorted $PGR at $247.36.
From @Grok (API): "Recommend SHORT on PGR as it's in a confirmed downtrend with EMA below SMA and price below both, no volume capitulation, and current bounce to 247.52 below EMA after positive earnings sets up for further declines toward supports around 240 over the next few weeks."